skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Comparative study of eicosapentaenoic acid metabolism by human platelets in vivo and in vitro

Journal Article · · J. Lipid Res.; (United States)
OSTI ID:5151058

During long-term dietary n-3 fatty acid supplementation, eicosapentaenoic acid (EPA) is not incorporated into phosphatidylinositol or -serine of human platelets in vivo and is not detectable in phosphatidic acid upon stimulation with thrombin. However, EPA is released from platelet phospholipids and metabolized to thromboxane B3 (TXB3). In contrast, in vitro, platelets incorporate (/sup 14/C)EPA into phosphatidylinositol, whether they contain endogenous EPA in their cellular lipids or not. Following platelet stimulation, (/sup 14/C)EPA appears in phosphatidic acid, as free fatty acid, and is transformed to TXB3. The authors conclude that the fatty acid compositions of platelet phospholipid subclasses are regulated with a high degree of specificity in vivo. Qualitative differences exist between in vivo and in vitro uptake of EPA into platelet phospholipid subclasses. After in vivo incorporation, EPA is released by action of a phospholipase A2.

Research Organization:
Universitaet Muenchen, Germany, F.R.
OSTI ID:
5151058
Journal Information:
J. Lipid Res.; (United States), Vol. 4
Country of Publication:
United States
Language:
English